DiaSys and Merck Centroamericana S.A. in Exclusive Two-Year Sales and Service Agreement; Reports Initial Orders Of 70,000 US Dollars.Business Editors WATERBURY, Conn.--(BUSINESS WIRE)--Oct. 1, 2002 DiaSys Corporation (AMEX AMEX See: American Stock Exchange : DYX DYX Dyslexia ), a global healthcare products company, today announced that it has entered into an exclusive two-year sales and service agreement with Merck Centroamericana S.A., a subsidiary of Merck KGaA This article needs sources or references that appear in reliable, third-party publications. Alone, primary sources and sources affiliated with the subject of this article are not sufficient for an accurate encyclopedia article. (XETRA Xetra Deutsche Borse electronic trading platform that commenced operation in 1997. : MRCG.DE), the world renowned pharmaceutical and chemistry products producer based in Darmstadt, Germany. Under the agreement, Merck Centroamericana S.A. will promote, sell and service DiaSys' medical equipment and consumable products in Guatemala, Honduras and Nicaragua. Merck Centroamericana S.A. has issued initial orders to DiaSys in the amount of US$70,000 for instrumentation and consumables focused primarily on urine sediment, electrophoresis and parasite analysis applications. Todd M. DeMatteo, DiaSys' President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , said, "We are delighted to welcome Merck Centroamericana S.A. to our growing team of international distributors. For several years we have been building an international sales and service network of the highest quality and reputation into which Merck Centroamericana S.A. clearly fits. Central and South America provide significant business opportunities for our laboratory instruments and consumables and Merck Centroamericana S.A. is the ideal partner to secure our market position." Thomas B. Schreier, Director of the Chemical Division of Merck Centroamericana S.A., added: "DiaSys' products fit very nicely into our strategy to bring modern - yet affordable and easy to handle - technology to the clinical laboratories of our countries." DiaSys Corporation designs, develops, manufactures and distributes proprietary medical laboratory equipment, consumables and test kits to healthcare laboratories worldwide. Headquartered in Waterbury, CT, the Company operates in Europe through its wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. based in Wokingham, England and in Pacific Asia through its strategic business partner located in Guangzhou, China. The foregoing press release includes "forward looking statements" within the meaning of, and made pursuant to, the safe harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Such forward looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance or achievements of the Company or events, or timing of events, relating to the Company to materially differ from those expressed or implied by such forward looking statements. DiaSys refers interested parties to its most recent Annual Report on form 10-KSB and other SEC filings for a complete description of, and discussions about, the Company. |
|
||||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion